Synthesis and structure–activity relationship of dehydrodieugenol B neolignans against Trypanosoma cruzi
Trypanosoma cruzi is the etiologic agent of Chagas disease, which affects over seven million people, especially in developing countries. Undesirable side effects are frequently associated with current therapies, which are typically ineffective in the treatment of all stages of the disease. Here, we...
Главные авторы: | Sear, CE, Pieper, P, Amaral, M, Romanelli, MM, Costa-Silva, TA, Haugland, MM, Tate, JA, Lago, JHG, Tempone, AG, Anderson, EA |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
American Chemical Society
2020
|
Схожие документы
-
Biological activity and structure–activity relationship of dehydrodieugenol B analogues against visceral leishmaniasis
по: Amaral, M, и др.
Опубликовано: (2023) -
Dehydrodieugenol B derivatives as antiparasitic agents: synthesis and biological activity against Trypanosoma cruzi
по: Ferreira, D, и др.
Опубликовано: (2019) -
Structure-activity relationship study of cytotoxic neolignan derivatives using multivariate analysis and computation-aided drug design.
по: de Sousa, FS, и др.
Опубликовано: (2020) -
Synthesis and anti-parasitic activity of dehydrodieugenol B and analogues
по: Sear, C
Опубликовано: (2020) -
Exploring Synthetic Dihydrobenzofuran and Benzofuran Neolignans as Antiprotozoal Agents against <i>Trypanosoma cruzi</i>
по: Mariana C. Pagotti, и др.
Опубликовано: (2023-02-01)